abstract |
The current invention relates to the use of an RAR antagonist or an RAR inverse agonist for the manufacture of a medicament for the treatment of hyperlipidemia in a mammal and to an RAR antagonist or an RAR inverse agonist for use in a method for the treatment of hyperlipidemia in a mammal. |